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The serotonin-sensitive aryl acylamidase was partially purified from monkey brain. The aryl 
acylamidase activity was inhibited by serotonin (Ki = 0.425 mM) and tryptamine (Ki = 3.6 mM) 
but not by a number of other amines. It was also inhibited by acetylcholine (Ki = 2 mM) and its 
analogues and homologues. The relationship of aryl acylamidase to acetylcholinesterase was 
examined. The ratios of specific activities of aryl acylamidase and acetylcholinesterase in the different 
steps of purification were approximately constant and the percentage recoveries of both enzyme 
activities were comparable. Elution profiles of both enzyme activities from concanavalin-A - 
Sepharose, Sephadex G-200 and DEAE-Sephadex A-25 columns were similar. Both enzyme activities 
migrated in a similar fashion on gel electrophoresis in different percentage gels for different time 
intervals. Both enzymes showed similar distribution in the various anatomical regions and in the 
different subcellular fractions of monkey brain. 
Eserine and neostigmine, potent competitive inhibitors of acetylcholinesterase also potently 
inhibited aryl acylamidase in a non-competitive manner. Inhibition of both enzymes was 100% at 
10 pM of both the inhibitors. Tetraisopropylpyrophosphoramide, a selective inhibitor of pseudo- 
cholinesterase, did not inhibit either the brain acetylcholinesterase or aryl acylamidase at 10 pM. 
Serotonin inhibited acetylcholinesterase only at concentrations above 10 mM. Dixon plots of one 
inhibitor in the presence of additional inhibitors indicated that serotonin, butyrylcholine, acetyl- 
choline, neostigmine and eserine (all non-competitive inhibitors of aryl acylamidase) acted at the 
same site as inhibitors of aryl acylamidase. 
The serotonin-insensitive aryl acylamidase of monkey liver was also insensitive to acetylcholine 
and eserine and was not found associated with acetylcholinesterase [A. Oommen and A. S. Bala- 
subramanian (1978) Biochem. Pharmacol. 27, 891 - 8951. Erythrocyte membrane known to contain 
true cholinesterase had aryl acylamidase activity sensitive to serotonin, acetylcholine and eserine. 
All these considerations suggest that the serotonin-sensitive aryl acylamidase activity is a property 
of true cholinesterase. Although some of the experimental results would suggest that in the monkey 
brain the two activities may be associated with the same protein with two different active sites further 
experiments are needed to confirm this. 
The existence of a serotonin-sensitive aryl acyl- 
amidase in the rat brain was first reported by Fuji- 
mot0 [l]. Since the enzyme was specifically sensitive 
to serotonin it was suggested that the brain aryl acyl- 
amidase could serve as a model for the study of the 
mechanism of action 'of serotonin in the central 
nervous system [l]. The uniqueness of the enzyme lies 
in the fact that it is sensitive to serotonin when prepared 
from the brain tissue but not from the liver [1,2]. We 
confirmed these observations of Fujimoto in the sheep 
and monkey brain and further observed that acetyl- 
Enzymes. Aryl acylamidase or aryl acylamide amidohydrolase 
(EC 3.5.1.13); acetylcholinesterase (EC 3.1.1.7). 
choline and several of its analogues and homologues 
also inhibit the brain enzyme but not the liver enzyme 
[3,4]. Fujimoto independently reported that purified 
acetylcholinesterase of E. electricus has aryl acyl- 
amidase activity which is serotonin-sensitive [5]. We 
have therefore considered the possibility of the asso- 
ciation of the serotonin-sensitive aryl acylamidase with 
acetylcholinesterase in the brain. In an earlier commu- 
nication [4] we reported that preparations of aryl 
acylamidase from monkey brain and liver differ from 
each other in their sensitivity to inhibitors, molecular 
weight and thermal stability. Furthermore, on Se- 
pharose gel filtration acetylcholinesterase activity co- 
eluted with aryl acylamidase activity from monkey 
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brain but not from monkey liver. These results and a 
study of the regional distribution of aryl acylamidase 
in monkey brain were considered as preliminary in- 
dications of a close relationship between brain aryl 
acylamidase and acetylcholinesterase. In the present 
communication we report several lines of evidence 
which suggest the association of the serotonin-sensi- 
tive aryl acylamidase with acetylcholinesterase in the 
monkey brain. 
MATERIALS AND METHODS 
The various amines, S-methoxytryptamine, 5- 
hydroxyindole-3-acetic acid, tetraisopropylpyrophos- 
phoramide, eserine sulphate, acetylcholine iodide and 
related choline derivatives, m-a-phosphatidylcholine 
dipalmitoyl and trypsin inhibitor (soyabean) were 
from Sigma Chemical Co. (U.S.A.); pronase, B grade 
and aquacide I1 from Calbiochem (U.S.A.), trypsin 
(20000 Fuld-Gross units/g) from E. Merck (F.R.G.), 
a-chymotrypsin (thrice crystallized) from Worthing- 
ton (U.S.A.) and neostigmine methylsulphate from 
Roche Products Ltd (India). Concanavalin A from 
Canavalia gladiata was prepared according to the meth- 
od of Surolia et al. [6] and coupled to Sepharose 4B 
(activated at pH 8.5 in 0.1 M sodium bicarbonate 
buffer 171) according to the method of Cuatrecasas 
and Parikh [8]. The final preparation had 12 mg 
concanavalin A per ml Sepharose 4B. All other chem- 
icals were obtained as described earlier [3]. Monkey 
(Macaca radiara) brain was obtained immediately 
after sacrifice of the animal under Nembutal anaes- 
thesia and stored frozen at - 18 "C until required. 
Purification of Morzkey Brain Ary f Acylunzidasr 
and Acetylcholinesterase 
unless otherwise mentioned. 
All operations were carried out between 0-4 "C 
Extraction and Ammonium Sulphate Fractionation 
Monkey brain (1OOg) was homogenized with 
200 ml of 0.05 M potassium phosphate buffer pH 7.0 
containing 0.5% (v/v) Triton X-100 in a Potter- 
Elvehjem homogenizer. The homogenate was kept for 
60 min and then centrifuged at 12000 x g for 30 min. 
The supernatant was subjected to ammonium sulphate 
fractionation using solid ammonium sulphate and the 
fraction precipitating between 30 to 65 saturation 
of ammonium sulphate was collected by centri- 
fugation at 12000 x g for 30 min. It was dissolved 
using 5 ml of 0.05 M potassium phosphate buffer 
pH 7.0 and dialyzed against 100 volumes of the 
same buffer for eights hours with four changes. 
Concanavalin-A - Sepharose Chromatography. The 
dialyzed ammonium sulphate fraction (20 ml) was 
kept in contact with 35 ml of Concanavalin-A-Se- 
pharose for 48 h with frequent stirring. It was then 
poured into a column (13 x 1.8 cm) and washed with 
10 bed volumes of 0.05 M potassium phosphate buffer 
pH 7.0 containing 0.5 M NaCl. Elution was carried 
out with 0.5 M a-methyl glucoside in the wash buffer. 
The column was kept in contact with 35 ml of the 
eluting buffer for 3 h before elution was started. 
Elution was performed at a flow rate of 10 ml/h and 
fractions of 5 nil were collected. The active fractions 
(4- 11) were pooled and concentrated with Aquacide 
11 to approximately 2 ml. 
Sephadex G-200 Gel Filtration. The concentrated 
concanavalin A eluate (1.8 ml) was next subjected to 
gel filtration on a Sephadex G-200 column (26.5 
x 2.2 cm) previously equilibrated with 0.05 M po- 
tassium phosphate buffer pH 7.0 containing 0.1 M 
NaCl at a flow rate of 8 ml/h. The first 24 ml of effluent 
was collected in bulk and thereafter 2-ml fractions 
were collected. The active fractions (3 - 9) were pooled 
and concentrated with Aquacide I1 to approximately 
0.7 ml and then dialyzed against 70 volumes of 0.05 M 
potassium phosphate buffer pH 7.0 for 6 h with two 
changes. 
Unless otherwise mentioned this concentrated and 
dialyzed Sephadex G-200 fraction was used as the 
source of enzyme. 
Polyacrylarnide Gel Electrophoresis 
Polyacrylamide gel electrophoresis was carried 
out according to the method of Davis [9] on 3.50/,, 
5 %  and 7 %  gels at pH 8.0 in 0.05 M Tris-glycine 
buffer and on 5 %  gels at pH 5.0 in 0.05 M p-alanine 
buffer a t  3 mA/tube. The applied sample consisted of 
0.15 ml enzyme together with 0.02 ml glycerol and 
0.02 ml of tracking dye, Electrophoresis in the pH 8.0 
buffer was run for different time intervals, viz. for 
1 h and 20 min when the tracking dye (bromophenol 
blue) emerged from the gel tubes, and for 4 h. Similar 
electrophoretic runs were made at pH 5.0 using 
methylene green, as the tracking dye. At the end of 
the runs the gels were sliced into sections of 3-mm 
thickness and each section homogenized with 1 ml 
of 0.05 M potassium phosphate buffer pH 7.0 contain- 
ing 0.5% (v/v) Triton X-100 and 0.1 M NaC1. The 
homogenate was kept at 4 "C for 24 h with frequent 
shaking and then centrifuged to settle the gel particles. 
Enzyme assays for both aryl acylamidase and acetyl- 
cholinesterase were carried out with 0.2 ml aliquots 
of the supernatants. Incubation was at 28 "C for 24 h 
for aryl acylamidase and at 37 "C for 10 min for acetyl- 
cholinesterase. 
The gels were stained for protein with Coomassie 
brilliant blue. Sodium dodecyl/polyacrylamide gel 
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electrophoresis was carried out according to Weber 
and Osborn [lo] with and without 2-mercaptoethanol 
treatment. 
SubceElular Fractionation 
and Regional Distribution Studies 
Subcellular fractionation of the monkey brain was 
carried out according to the method of Eichberg et 
al. [ll],  using one hemisphere of freshly obtained 
whole monkey brain. 
When studying the distribution of aryl acylamidase 
and acetylcholinesterase in the different regions of the 
monkey brain, each region was homogenized in 2 
volumes of 0.05 M potassium phosphate buffer pH 7.0 
containing 0.5 (v/v) Triton X-100 and these homog- 
enates were used for the assay of the enzymes. 
Proteolytic Treatment of' the Purified Enzyme 
Trypsin Treatment. The purified enzyme (2 mg) 
was incubated with 0.2 mg of trypsin in a total volume 
of 0.7 ml in 0.05 M potassium phosphate buffer 
pH 7.0. After incubation for 1 h at 37 "C the reaction 
was stopped with 0.2 mg trypsin inhibitor and the 
mixture chilled in ice for 3 min. 
a-Chymotrypsin Treatment. The purified enzyme 
(2 mg) was treated with 0.07 mg a-chymotrypsin in 
0.05 M potassium phosphate buffer pH 7.0 in a total 
volume of 0.57 ml. After incubation for 1 h at 37 "C 
the mixture was chilled in ice for 3 min. 
Pronase Treatment. The purified enzyme (3.25 mg) 
was incubated with 0.06 mg pronase in 0.05 M po- 
tassium phosphate buffer pH 7.0 in a total volume of 
0.62 ml for 30 min at 37 "C and then chilled in ice for 
3 min. 
The protease-treated enzyme samples were sub- 
jected to gel filtration and polyacrylamide gel electro- 
phoresis at the end of incubation periods as described 
above. 
Aryl Acylamidase Assay 
Aryl acylamidase was assayed according to a modi- 
fied method of Hoagland and Graf [I21 as described 
earlier [3]. The assay system consisted of 50 pmol 
potassium phosphate buffer pH 7.0, 4.5 ymol of o- 
nitroacetanilide and enzyme in a total volume of 
0.5 ml. Incubation was carried out for 2 h at 37°C 
and the absorbance of liberated o-nitroaniline read 
at 430 nm. Reaction rates in all the assays were linear 
with respect to time and protein concentration. One 
enzyme unit (U) is defined as the amount of enzyme 
required to produce 1 pmol of o-nitroaniline in 1 h 
under the standard assay conditions. 
Acetylcholinesterase Assay 
Acetylcholinesterase was assayed according to 
the method of Ellman et al. [13]. In a total volume of 
0.5 ml, 50 pmol potassium phosphate buffer pH 8.0, 
1.5 pmol acetylthiocholine iodide, 0.1 ml 5,5'-dithio- 
bis(2-nitrobenzoic acid) reagent and enzyme (suitably 
diluted in 0.05 M potassium phosphate buffer pH 7.0) 
were incubated for 10 min at 37 "C. The reaction was 
stopped with 0.5 ml of 1 mM eserine sulphate and 
the absorbance of liberated product read at 412 nm. 
In all the studies, reaction rates were linear with respect 
to time and protein concentration. One enzyme unit 
(U) is defined as the amount of enzyme which produces 
a change of 0.001 in absorbance at 412 nm in 1 min 
under the standard assay conditions. 
Prot ein Est irnat ion 
Protein was estimated according to the method of 
Lowry et al. [14] using crystalline bovine serum al- 
bumin as standard. 
Specific activity is defined as enzyme units per mg 
protein. Spectrophotometric measurements were made 
in a Carl Zeiss spectrophotometer. 
RESULTS 
Purijkation of Aryl Acylamidase 
and Acetylcholinesterase 
Using a combination of ammonium sulphate 
fractionation, concanavalin-A - Sepharose affinity 
chromatography [15], and Sephadex G-200 gel filtra- 
tion a partial purification of the monkey brain aryl 
acylamidase and acetylcholinesterase was achieved 
(Table 1). Keeping the enzyme with concanavalin-A - 
Sepharose for 48 h was found to be necessary for maxi- 
mal binding of aryl acylamidase to concanavalin A. 
The overall purification was approximately twenty- 
fold over the homogenate with the affinity technique 
providing about seven-fold purification. In both the 
concanavalin-A - Sepharose chromatography and Se- 
phadex G-200 gel filtration steps aryl acylamidase and 
acetylcholinesterase co-eluted (Fig. 1). Furthermore 
as shown in Table 1 the ratios of the specific activities 
of aryl acylamidase and acetylcholinesterase were 
approximately constant in the different steps of purifi- 
cation and the percentage recoveries of the two en- 
zymes at each step was about the same. 
In an attempt to further purify the enzyme the 
Sephadex G-200 fraction was subjected to DEAE- 
Sephadex A-25 chromatography and linear gradient 
elution with NaCl. Although little purification and 
poor recoveries resulted, it was found that both the 
enzymes were eluted in the same fractions at this step 
also. 
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Table 1. Purification of monkey brain aryl acylamidase and acetylcholinesterase 
Values are the average of 5 different sets of experiments. See Methods for details and definitions of enzyme units and specific activity 
Fraction Volume Total Total enzyme activity Specific activity Recovery alb 
protein ~ _ _ _ _ _ . ~  
a b 
aryl- acetyl- aryl- acetyl- aryl- acetyl- 
acyl- cholin- acyl- cholin- acyl- cholin- 
amidase esterase amidase esterase amidase esterase 
ml mg U U/mg 2l 
~ _ _  ~~ ~~ ~~~ __ 
Homogenate 290 12 227 544.43 5943250 0.045 486.1 100 3 00 0.925 
12000 x g  supernatant 109 2 348 196.4 I508485 0.084 642.5 36 25.4 1.3 
30-65 % (NH4)2S04 20 607 78.5 732830 0.129 1207.3 14.4 12.3 1.06 
Concentrated 
concanavalin A fraction 2.36 17.55 16.02 125745 0.913 7165 2.9 2.1 1.27 
Sephadex G-200 fraction 0.78 5.61 5.22 49610 0.931 8843 0.96 0.84 1.05 
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Fig. 1. Ehttion projiles of aryl acylamidase and acetylcholinesteruse. 
(A) From the concanavalin-A - Sepharose column; (B) from the 
Sephadex G-200 column. See Methods for details. (0) Aryl acyl- 
amidase ; (0) acetylcholinesterase 
Although the ratios of specific activities of aryl 
acylamidase and acetylcholinesterase of the pooled 
concentrated fractions from the affinity column and 
Sephadex G-200 were approximately the same as in 
the other steps of purification (Table 1) a variation in 
the ratio of activities among the individual fractions 
after elution from concanavalin-A - Sepharose or 
Sephadex G-200 was noticed. In the affinity column 
step a 1.5- 1.8-fold variation in the ratio of activities 
was observed as judged from three different experi- 
ments and in Sephadex G-200 gel filtration a 1.6- 
2.6-fold variation was seen in four different experi- 
ments. 
Gel slice 
Fig. 2. Polyacrylamidr gel electrophoresis on 5 %gels in 0.05 M Tris- 
glycine buffer pH 8.0. Gels were cut into 3-mm thickness starting at 
the origin of the separating gel. Gel slice number 1 includes the 
origin. For details see text. Aryl acylamidase (0) and acetylcholin- 
esterase (0) activity profiles after polyacrylamide gel electrophoresis 
for 1 h 20 min 
Polyacrylamide Gel Electrophoresis 
of Aryf Acylamidase and Acetylcholinesterase 
Both aryl acylamidase and acetylcholinesterase 
were observed to co-migrate when subjected to gel 
electrophoresis on polyacrylamide gels of different 
concentration (3 .5%, 5 %  and 7%) as well as for 
different lengths of time. In Fig. 2 is shown the migra- 
tion of the enzyme activities after gel electrophoresis 
for 1 h 20 min on 5 % gels at pH 8.0. Both aryl acyl- 
amidase and acetylcholinesterase showed the same 
pattern of electrophoretic movement. During this 
period of electrophoresis a major peak of the enzyme 
activity remained at or near the origin with a second 
peak of activity on the separating gel (Fig. 2). During 
a 4 h electrophoresis the second peak of activity of 
both aryl acylamidase and acetylcholinesterase was 
found to further migrate into the separating gel as a 
diffused band of activity spread out in gel numbers 
6 to 12 with a minor peak in gel number 10. The 
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Table 2. Inhibition of brain aryl acylamidase by amines and choline 
derivatives 
Inhibitors were tested at 1 mM 
Inhibitor Inhibition 
x 
Serotonin creatinine sulphate 
Tryptamine hydrochloride 
Succinylcholine chloride 
Butyrylcholine iodide 
Propionylcholine chloride 
Acetyl-P-methylcholine bromide 
Acetylcholine iodide 
Choline chloride 
Benzoylcholine chloride 
Acetylthiocholine iodide 
83 
34 
58 
60 
36 
33 
35 
38 
44 
21 
major peak of activity due to both enzymes remained 
near the origin even after 4 h of electrophoresis. The 
same pattern of migration for the two enzymes was 
observed with 7.0 ”/, and 3.5 % gels. The major enzyme 
activity near the origin may represent a higher molec- 
ular weight component or an aggregated form of the 
enzyme. 
Staining for protein after gel electrophoresis (1 mg 
protein on 5 % gel for 1 h 20 min) showed two closely 
spaced bands near the origin, two faint bands nearer 
the anode and a diffused band in between. The sodium 
dodecyl gel electrophoretic pattern with or without 
2-mercaptoethanol treatment showed one protein 
band near the origin and about seven closely spaced 
faint bands in the middle of the gel. 
When electrophoresis was carried out in pH 5.0 
buffer no aryl acylamidase or acetylcholinesterase 
activity was detectable in the gels, possibly due to in- 
activation of the enzymes or non-entry of the enzymes 
into the gel. 
Inhibition of Aryl Acylamidase 
by Various Amines and Choline Derivatives 
It was shown in earlier studies that serotonin and 
some choline derivatives inhibit the sheep brain aryl 
acylamidase maximally around 1 mM. In Table 2 is 
shown the percentage inhibition of monkey brain 
aryl acylamidase by the amines and choline deriva- 
tives at 1 mM. Among the amines only serotonin and 
tryptamine were found to inhibit the enzyme with Ki 
values of 0.425 mM and 3.6 mM respectively as meas- 
ured by Dixon plots. Tryptophan, 5-methoxytrypto- 
phan, 5-methoxytryptamine and 5-hydroxyindole-3- 
acetic acid were ineffective as inhibitors. The following 
monoamines and polyamines also did not have any 
significant inhibition on the enzyme at 1 mM: dop- 
amine (3,4-dihydroxyphenethylamine), tyramine, hist- 
Table 3. Inhibition of’ aryl acylamidase and acetylcholinesterase by 
acetylcholinesterase inhibitors 
Inhibitor Concentration Inhibition 
________. ~ 
aryl acetylcholin- 
acylamidase esterase 
% 
~~ 
FM 
Eserine 1 
10 
90 48 
100 100 
- Neostigmine 1 90 
93 
10 100 100 
- 7.5 
Tetraisopropyl- 
pyrophosphor- 
amide 10 0 0 
I00 19 0 
amine, benzylamine, norepinephrine, taurine, sper- 
mine and spermidine. 
Choline, acetylcholine (Ki = 2 mM) and a number 
of their homologues and analogues were also inhibi- 
tory to the brain aryl acylamidase (Table 2). However 
the phospholipid dipalmitoyl phosphatidylcholine at 
1 mM was not found to inhibit the enzyme. 
Inhibition of Aryl Acylamidase 
by Acetylcholinesterase Inhibitors 
Eserine and neostigmine which are known to be 
potent inhibitors of acetylcholinesterase were also 
highly inhibitory to the brain aryl acylamidase. Con- 
centrations of 10 pM of either of these inhibitors caused 
a 100% inhibition of both enzyme activities. Tetra. 
isopropylpyrophosphoramide known to be a selective 
inhibitor of pseudocholinesterase at 10 pM [16] was 
observed to have no inhibitory effect on either aryl 
acylamidase or acetylcholinesterase at this concentra- 
tion (Table 3). 
Nature of Inhibition of Aryl Acylamidase 
and Acetylcholinesterase by the Various Inhibitors 
Lineweaver-Burk plots showed that serotonin, 
tryptamine, acetylcholine, butyrylcholine, eserine and 
neostigmine were non-competitive inhibitors of brain 
aryl acylamidase (Fig. 3). The non-competitive nature 
of inhibition by serotonin and acetylcholine was 
shown earlier [l - 31. 
Eserine and neostigmine were found to be compe- 
titive inhibitors of the brain acetylcholinesterase 
(Fig. 4). Serotonin was found to inhibit acetylcholin- 
esterase only at high concentrations, about 50 % in- 
hibition at 10 mM concentration of serotonin. Similar 
in nature was the inhibition of acetylcholinesterase by 
tryptamine. The l/[S] against l / v  plots for the inhibi- 
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tion of acetylcholinesterase by serotonin showed a 
considerable scattering of the experimental points 
repeatedly and it was uncertain whether the inhibition 
was a competitive type or a mixed (competitive-non- 
competitive) type. The reasons for this finding are not 
obvious but it has been pointed out [17] that the amines 
spermine and spermidine can interact with and cause 
a non-enzymic hydrolysis of acetylthiocholine and 
their inhibition of acetylcholinesterase was more at 
higher substrate concentrations. Apparently more de- 
tailed investigations into the nature of inhibition of the 
monkey brain acetylcholinesterase by serotonin will 
be needed. 
Semenza and Balthazar [18] have shown that the 
Dixon plot of one inhibitor is changed by the presence 
of an additional inhibitor at constant concentration 
and that when the two inhibitors compete with each 
other, the Dixon plots obtained in the presence and in 
the absence of the additional inhibitor are parallel. 
Semenza-Balthazar plots of aryl acylamidase when in- 
hibited by serotonin together with butyrylcholine, 
neostigmine, eserine or acetylcholine gave approxima- 
tely parallel plots (Fig.5) suggesting that all the five 
non-competitive inhibitors of brain aryl acylamidase 
act at the same site on the enzyme. 
Regional Distribution of Aryl Acylanziduse 
and Acetylcholinestevuse in the Monkey Brain 
A study of the regional distribution of both aryl 
acylamidase and acetylcholinesterase in the monkey 
brain indicated a parallel distribution profile of both 
enzymes in the different regions (Table 4). The region 
of highest specific activity for both aryl acylamidase 
and acetylcholinesterase was the basal ganglia followed 
by the pons. 
1.6 r 
Monkey Brain Subcellular Distribution 
of Aryl Acylamidase and Acetylcholinesterase 
A study of the intracellular distribution of aryl 
acylamidase and acetylcholinesterase in the monkey 
brain showed that both enzymes had a similar distribu- 
tion profile in the subcellular organelles (Table 5). 
The maximum specific activity of both enzymes was 
in the microsoinal fraction followed by the small 
myelin and synaptosomal fractions. 
0 0.2 0.4 0.6 Q8 1.0 1.2 1.4 1.6 1.8 2.0 
1/[S] (rnM”) 
Fig. 3. Lineweaver-Burk plots OJ‘ the velocity of aryl acylamidase as 
a function of the concentration of’ o-nitroacetanilide and with various 
inhibitors. In the absence of any inhibitor (0); in the presence of 
4 mM acetylcholine iodide ( x ) ;  1 mM tryptamine HCI (0); 1 mM 
butyrylcholine chloride (H); 0.2 mM serotonin creatinine sulphate 
(0), 40 nM eserine sulphate (A) and 20 nM neostigmine methyl- 
sulphate (A) 
0.10 - 
0.08 - 
0.06 - 
L . - 
0.04 - 
Proteolytic Treatment 
03 Aryl Acylumidase and Acetylcholinesterase 
The purified monkey brain enzyme containing 
acetylcholinesterase and aryl acylamidase activities 
was subjected to proteolytic digestion with trypsin, 
a-chymotrypsin or pronase as given under methods. 
Trypsin and a-chymotrypsin caused a 40 % decrease 
in activities of both enzymes after 60 min of incubation 
at 37 “C while pronase treatment for 30 min under the 
conditions described did not cause any loss in either 
enzyme activity. 
- I 
0 2 4 6 8 10 12 14 16 18 
l/[S] (rnM-’) 
Fig. 4. Lineweaver-Burk plots of the ve/ocity of acetylcholinesterase as ajunction of the concentrution of acetylthiocholine iodide in the presence 
and absence o/ inhibitor. No inhibitor (0); in the presence of 40 nM eserine sulphate (A); in the presence of 0.3 pM neostigmine methyl- 
sulphate (A) 
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Fig. 5. Dhon plots of monkey brain aryl acylamidase for inhibitors mutually competing. Dixon plot of serotonin (0); serotonin with 30 nM 
neostigmine methylsulphate (A); serotonin with 1 mM butyrylcholine chloride (0); serotonin with 40 nM eserine sulphate (A); and serotonin 
with 4 mM acetylcholine iodide (0) 
Table 4. Regional distribution of aryl acylamidase and ucetylcholin- 
esterase in the monkey brain 
Values are the mean of two sets of experiments. See Methods for 
details 
Region Specific activity 
aryl acetylchoiin- 
acylamidase esterase 
Basal ganglia 
Pons 
Cerebellum 
Mid-brain 
Medulla oblangata 
Temporal cortex 
Parietal cortex 
Frontal cortex 
Corpus callosum 
Occipital cortex 
0.907 
0.128 
0.094 
0.084 
0.065 
0.039 
0.03 
0.028 
0.025 
0.02 
1548.5 
623.2 
410.4 
514.4 
337.6 
438.7 
174.0 
194.8 
346.0 
138.4 
Proteolytic treatment and subsequent Sephadex 
G-200 gel filtration showed that such treatment did 
not significantly change the elution profile of both 
the enzyme activities. Similarly, gel electrophoresis 
after protease treatment did not significantly alter 
the migration patterns of both the enzyme activities. 
DISCUSSION 
The specific inhibition of the purified monkey 
brain aryl acylamidase by serotonin and tryptamine 
but not other amines confirms the earlier findings 
[3]. Furthermore the inability of tryptophan or 5- 
hydroxyindole acetic acid to inhibit indicates that the 
Table 5. Subcellular distribution of aryl acylumidasr and acetyl- 
cholinesterase in monkey brain 
See Methods for details 
Fraction Specific activity 
aryl acetylcholin- 
acylamidase esterase 
PI (Crude nuclear) 0.048 220 
PzC (Mitochondria) 0.033 183 
PzB (Synaptosomes) 0.056 303 
P2A (Small myelin) 0.075 516 
s3 (Cytosol) 0.052 243 
P3 (Microsomes) 0.105 549 
indole ethyl amine structure is the basic requirement 
for inhibition. The inability of 5:methoxytryptamine to 
inhibit suggests that a substitution in the 5-hydroxy 
group can cause a drastic change in the inhibitory 
capacity. The inhibition by several of the acetyl- 
choline analogues and homologues also confirms the 
earlier findings [3]. The choline moiety appears to be 
essential for this inhibition though interestingly phos- 
phatidylcholine does not inhibit the enzyme. 
Our observations of the acetylcholine inhibition of 
aryl acylamidase coupled with the report of Fuji- 
mot0 [5] that Electrophorus electvicus acetylcholin- 
esterase has aryl acylamidase activity prompted us to 
study the relationship between the two enzymes in 
the monkey brain. The following lines of evidence 
suggest a close association of the acetylcholinesterase 
and aryl acylamidase activities in the monkey brain. 
Firstly, the ratio of specific activities of both the en- 
zymes at the various steps of purification of the enzyme 
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is approximately constant. Moreover the recovery 
of both the enzyme activities at the different steps of 
the purification procedure is also of the same order. 
Secondly, the elution profiles of both the enzyme ac- 
tivities from the concanavalin-A - Sepharose column, 
Sephadex G-200 column and DEAE-Sephadex col- 
umns were found to be the same. Thirdly, both enzyme 
activities co-migrate in gel electrophoresis when run 
in different percentage gels for different time intervals. 
Fourthly, potent inhibitors of acetylcholinesterase 
viz. eserine and neostigmine completely inhibit both 
aryl acylamidase and acetylcholinesterase of monkey 
brain at 10 pM. Eserine inhibition at a concentration 
as low as 10 pM is a distinguishing feature of cholin- 
esterase from non-specific esterases [ 191. Fifthly, brain 
acetylcholinesterase is considered to be a true cholin- 
esterase and in the mouse brain it has been shown 
to be almost 99% true cholinesterase [20]. When 
tetraisopropylpyrophosphoramide which selectively 
inhibits pseudocholinesterase at 10 pM [16] was used 
there was no inhibition of either acetylcholinesterase 
activity or aryl acylamidase activity of the inonkey 
brain enzyme. Sixthly, the distribution profile of both 
aryl acylamidase and acetylcholinesterase activities 
in the various anatomical regions of monkey brain 
closely resemble each other. The basal ganglia fol- 
lowed by the pons showed the highest activities. 
Finally, the subcellular distribution of both enzymes 
are identical with the highest specific activities in the 
microsomal fraction. 
Apart from these observations the fact that monkey 
liver aryl acylamidase which is insensitive to sero- 
tonin and acetylcholine is also insensitive to eserine 
and is not found associated with acetylcholinesterase 
[4] lends further support to the postulation that the 
brain aryl acylamidase which is sensitive to serotonin 
is alone associated with acetylcholinesterase. Whether 
the absence of true cholinesterase in the liver is re- 
sponsible for the observed differences between the 
brain and liver is not at present clear. We have observed 
that aryl acylamidase from several non-neural tissues 
of the rat such as the liver, spleen, kidney, intestine, 
lung and heart do not show the serotonin sensitivity 
but the enzyme from erythrocyte membranes which 
is known to contain almost 94 % true cholinesterase 
activity [20] shows a significant sensitivity to serotonin, 
acetylcholine and eserine (55, 52 and 79% inhibition 
at 0.2 mM, 4 mM and 10 pM concentrations of the 
inhibitors respectively) and is insensitive to tetraiso- 
propylpyrophosphoramide at concentrations studied 
for the brain enzyme (unpublished data). 
Some of the experimental results indicate that the 
active sites for the brain aryl acylamidase and acetyl- 
cholinesterase reside at different loci in the same pro- 
tein. Eserine and neostigmine which are competitive 
inhibitors of monkey brain acetylcholinesterase clearly 
show a non-competitive inhibition of aryl acylamidase. 
Added to this is the fact that acetylcholine which is a 
substrate for acetylcholinesterase acts as a non-compe- 
titive inhibitor of aryl acylamidase. Plots according to 
Semenza and Balthazar suggest that the non-compe- 
titive inhibitors of aryl acylamidase viz. butyryl- 
choline, acetylcholine, neostigmine, eserine and sero- 
tonin act at the same site. It is possible that this 
common site of inhibition could be the active site of 
acetylcholinesterase. Attempts at separation of the 
aryl acylamidase and acetylcholinesterase activities 
by proteolytic treatment and subsequent gel filtration 
or electrophoresis were unsuccessful because with the 
three proteases tried both enzymes lost considerable 
activity during incubation periods beyond 1 h. 
Variations in the ratio of specific activities of aryl 
acylamidase and acetylcholinesterase have been ob- 
served among the eluted fractions of the enzyme from 
the concanavalin-A - Sepharose and Sephadex G-200 
columns. Similar variations were also observed among 
the subcellular fractions and anatomical regions of 
the monkey brain. Acetylcholinesterase of brain is 
known to exist in different molecular forms [21-231 
and it is not clear from the present experiments whether 
aryl acylamidase activity is associated with each form 
although the gel electrophoretic pattern would indi- 
cate that this may be so. It is also not known whether 
the same ratio of specific activities between the two 
enzymes is retained in all the different molecular forms. 
Moreover there is evidence for separate active sites 
for the two enzymes and inhibitors like serotonin or 
tryptamine are shown to affect the two activities to 
different extents. It is quite likely that endogenous 
factors present in the enzyme fractions could differen- 
tially affect the two activities and alter the ratio of 
specific activities. A final answer to these questions 
would depend upon purification of the brain enzyme 
to homogeneity. 
Serotonin sensitive aryl acylamidase activitiy thus 
appears to be a property of true cholinesterase. The 
physiological substrate for the serotonin-sensitive 
brain aryl acylamidase is not known. It is however 
likely that analgesic drugs which have an acetamido 
group may serve as substrates for the enzyme. The 
interesting possibility exists that higher levels of sero- 
tonin in the brain may help in the longer survival 
of such drugs in the brain by inhibiting the aryl acyl- 
amidase. 
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